AbbVie Inc. (NYSE: ABBV) has emerged as one of the standout performers in the latest round of analyst coverage, surging 41.4% over six months against a 28.4%
AbbVie (NYSE: ABBV) Leads Analyst Picks As NVIDIA (NASDAQ: NVDA) Trails Its Semiconductor Peers
Nov 12, 2026
